Megan L. Neely

Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry

Prognosis and Risks for Probable Chronic Lung Allograft Dysfunction: A Prospective Multicenter Study

Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

Lung function trajectories in patients with idiopathic pulmonary fibrosis

Additional file 7 of Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

Additional file 6 of Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression

Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis

Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction

Hospitalizations in patients with idiopathic pulmonary fibrosis

Circulating matrix metalloproteinases and tissue metalloproteinase inhibitors in patients with idiopathic pulmonary fibrosis in the multicenter IPF-PRO Registry cohort

Risk Factors for Acute Rejection in the First Year after Lung Transplant. A Multicenter Study

Peripheral blood proteomic profiling of idiopathic pulmonary fibrosis biomarkers in the multicentre IPF-PRO Registry

Predictors of death or lung transplant after a diagnosis of idiopathic pulmonary fibrosis: insights from the IPF-PRO Registry

RETRACTED: Screening for novel central nervous system biomarkers in veterans with Gulf War Illness

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population

The Learning Curve for Transradial Percutaneous Coronary Intervention Among Operators in the United States